Stock Markets Analysis & Opinion

First Bancorp (NASDAQ:FBNC) (FBP) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.27 per share a year ago....

It was an exciting day yesterday for Tesla (NASDAQ:TSLA) traders and investors. The stock price movement mirrored the major indices that saw wild swings.The markets plunged lower before recovering and...

Despite Monday’s nearly historic price swing that left the major indices closing in the positive, equity index futures were pointing lower on Tuesday. The Federal Reserve starts its two-day...

Reports Q2 2022 results on Tuesday, Jan. 25, after the market close Revenue Expectation: $50.65 billion EPS Expectation: $2.31 Investors are likely to see a familiar growth pattern when Microsoft...

For shareholders of Hexo (NASDAQ:HEXO) (TSX:HEXO), the past 12 months have been an up-and-down experience. And it could get even rockier as a deadline to reach a thus-far elusive milestone looms large...

Homebuilding heavyweight PulteGroup’s stock is down over 5% in January. Expected interest rate hikes and continued supply chain issues have put pressure on PHM stock as well as its...

A. O. Smith Corporation AOS is scheduled to report fourth-quarter 2021 results on Jan 27, before market open.The company delivered an earnings surprise of 16.82%, on average, in the trailing four...

Southern Missouri Bancorp (NASDAQ:SMBC) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.32 per share a...

The analysts are driving shares of Schlumberger (NYSE:SLB) higher and we think this is just the beginning of a very long trend. The entire oil industry is supported by fundamental factors that should...

Low-Volatility Stocks Are Appealing In Volatile Market ConditionsWhenever the market enters into correction territory, it’s incredibly important to review your portfolio and determine if any...

Nektar Therapeutics (NASDAQ:NKTR) is a $2B clinical trials biotech company, headquartered in San Francisco, CA. The stock has mostly been hovering around the $20 mark for most of Nektar’s 30+...

A few prominent chemical companies are scheduled to come up with their quarterly numbers on Jan 27. Per the Zacks industry classification, the chemical industry falls under the broader Basic Materials...

When we look at the International Business Machines (NYSE:IBM) stock price chart, we can see it trading a downtrend for the past week, falling lower and lower as the overall markets show weakness.The...

In the latest trading session, DuPont de Nemours (NYSE:DD) closed at $76.83, marking a -0.41% move from the previous day. This change was narrower than the S&P 500's daily loss of 1.22%....